IRCT20180430039488N2
Recruiting
Phase 3
Evaluation of the efficacy of intravenous administration of magnesium and pottasium solution in cardioversion of postoperative atrial fibrillation: a randomized, double blind, placebo-controlled trial
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Tehran University of Medical Sciences
- Enrollment
- 360
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Atrial fibrillation after isolated coronary artery bypass graft surgery
- •Continuation of atrial fibrillation rhythm for at least 15 minutes after initiation
- •Serum Potassium level of 4\-4\.5 meq/L
- •Serum Magnesium level of 4\-4\.5 meq/L
- •Informed consent to participate in the study
Exclusion Criteria
- •Unstable hemodynamic (systolic blood pressure less than 90 mmHg)
- •History of atrial fibrillation (persistent or paroxysmal) before surgery
- •Serum creatinine level more than 1\.4 mg/dl
- •More than 12 hours have passed since the beginning of the atrial fibrillation rhythm
- •Patients receiving packed cell
- •Hemoglobin level less than 7 g/L
- •Spontaneous cardioversion before randomization
- •Patients receiving Inotrope
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Evaluation of the effectiveness of intravenous infusion of human COVID-19 hyperimmune plasma with specific antibody titer in hospitalized patients with Covid-19: a randomized clinical trialIRCT20201004048922N1Tehran University of Medical Sciences75
Completed
Phase 2
Estimation of usefulness of intravenous admnistration of alendoronate for bone disorders after gastrectomyDistrubances of bone tissue metabolismJPRN-UMIN000012143Yokohama City University Medical Center46
Completed
Phase 3
A clinical trial to study the effect of conivaptan hydrochloride in patients with Euvolemic and Hypervolemic hyponatremia (a condition where the level of a chemical ion in blood goes below the normal levels)CTRI/2009/091/000400Ranbaxy Laboratories Limited75
Active, not recruiting
Not Applicable
Verification of the effectiveness of intravenous sildenafil compared to other pulmonary vasodilators used in the test vessel reactivity of pulmonarySubjects in children with congenital heart disease surgery or not, with echocardiographic signs of pulmonary hypertension followed at the Pediatric Cardiology Centre of the Mediterranean or reported by other centers I and Level II.MedDRA version: 14.1Level: SOCClassification code 10047065Term: Vascular disordersSystem Organ Class: 10047065 - Vascular disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2012-004583-22-ITOSPEDALE PEDIATRICO BAMBINO GESU' DI ROMA
Recruiting
Phase 1
Placenta-derived mesenchymal stem cells and placenta-derived mesenchymal stem cells exosomes in the treatment of acute GvHDAcute GvHD.Graft-versus-host diseaseD89.81IRCT20140818018842N40Tehran University of Medical Sciences60